IMPACT of PCSK9 inhibition on clinical outcome in patients during the inflammatory stage of the SARS-COV-2 infection: Rationale and protocol of the IMPACT-SIRIO 5 study

Affiliations

• ¹ Department of Cardiology and Internal Medicine, Collegium Medicum, Nicolaus Copernicus University, Poland.
• ² Department of Cardiology and Internal Medicine, Collegium Medicum, Nicolaus Copernicus University, Poland. przemo.podhajski@gmail.com.
• ³ Department of Health Promotion, Nicolaus Copernicus University, Collegium Medicum in Bydgoszcz, Poland.
• ⁴ Department of Endocrinology and Diabetology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Poland.
• ⁵ Centre of Postgraduate Medical Education, School of Public Health, Warsaw, Poland.